{"transactions":[{"id":775105,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-05-18T16:41:34.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":43.65,"expiration_date":"2036-01-21","underlying":"Common Stock","underlying_shares":32800},"source":{"system":"sec-edgar","filing":"0001752631-26-000003","document":"form4-05182026_080528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000003/form4-05182026_080528.xml","form_type":"4"}},{"id":775104,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-05-18T16:41:34.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":49.17,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":29200},"source":{"system":"sec-edgar","filing":"0001752631-26-000003","document":"form4-05182026_080528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000003/form4-05182026_080528.xml","form_type":"4"}},{"id":775103,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-05-18T16:41:34.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":91000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":46.31,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001752631-26-000003","document":"form4-05182026_080528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000003/form4-05182026_080528.xml","form_type":"4"}},{"id":775102,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T16:41:34.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64507,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Certain of these shares are represented by previously reported restricted stock units (\"RSUs\"). Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2026, by and among Soleno Therapeutics, Inc. (the \"Company\"), Neocrine Biosciences, Inc. (\"Parent\") and Sigma Merger Sub, Inc. (\"Merger Sub\"), on May 18, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding vested and unvested RSU was cancelled and converted into the right to receive an amount equal to $53.00 in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001752631-26-000003","document":"form4-05182026_080528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000003/form4-05182026_080528.xml","form_type":"4"}},{"id":824187,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:17:07.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":558,"price":31.7187,"value":17699.0346,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $31.64 to $31.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":64507,"source":{"system":"sec-edgar","filing":"0001752631-26-000002","document":"form4-04012026_120401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000002/form4-04012026_120401.xml","form_type":"4"}},{"id":824186,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:17:07.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":31.0384,"value":65180.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $30.545 to $31.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":65065,"source":{"system":"sec-edgar","filing":"0001752631-26-000002","document":"form4-04012026_120401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000002/form4-04012026_120401.xml","form_type":"4"}},{"id":824185,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:17:07.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":4864,"price":30.037,"value":146099.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.54 to $30.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":67165,"source":{"system":"sec-edgar","filing":"0001752631-26-000002","document":"form4-04012026_120401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000002/form4-04012026_120401.xml","form_type":"4"}},{"id":932386,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-01-23T18:06:06.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":32800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall vest on February 1, 2026 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."}],"balance_after":32800,"derivative":{"exercise_price":43.65,"expiration_date":"2036-01-21","underlying":"Common Stock","underlying_shares":32800},"source":{"system":"sec-edgar","filing":"0001752631-26-000001","document":"form4-01232026_110102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000001/form4-01232026_110102.xml","form_type":"4"}},{"id":932385,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T18:06:06.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":28600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. 100% of the RSUs shall vest on December 15, 2027, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":72029,"source":{"system":"sec-edgar","filing":"0001752631-26-000001","document":"form4-01232026_110102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263126000001/form4-01232026_110102.xml","form_type":"4"}},{"id":965105,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-17T16:38:30.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1922,"price":49.95,"value":96003.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units (\"RSUs\") which vested on December 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":43429,"source":{"system":"sec-edgar","filing":"0001752631-25-000004","document":"form4-12172025_091225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000175263125000004/form4-12172025_091225.xml","form_type":"4"}},{"id":1188016,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"One-fourth of the shares subject to the option vest on January 23, 2025 and one-forty-eighth of the shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date."}],"balance_after":91000,"derivative":{"exercise_price":46.31,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188015,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":37000,"price":67.0388,"value":2480435.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $67.00 to $67.271. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":45351,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188014,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":true,"shares":37000,"price":46.31,"value":1713470.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":82351,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188013,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":34,"price":72.6391,"value":2469.7294,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":45351,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188012,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":225,"price":71.7433,"value":16142.2425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":45385,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188011,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":155,"price":70.7341,"value":10963.7855,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":45610,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188010,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":1505,"price":69.8371,"value":105104.8355,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":45765,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188009,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":2599,"price":68.7881,"value":178780.2719,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":47270,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188008,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":1976,"price":67.7007,"value":133776.5832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":49869,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188007,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":1087,"price":66.7916,"value":72602.4692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":51845,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1188006,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-31T19:21:03.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":668,"price":65.9691,"value":44067.3588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":52932,"source":{"system":"sec-edgar","filing":"0001415889-25-009296","document":"form4-03312025_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925009296/form4-03312025_110359.xml","form_type":"4"}},{"id":1296431,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-01-23T16:28:33.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":29200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall vest on February 1, 2025 and 1/48th of the remaining shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."}],"balance_after":29200,"derivative":{"exercise_price":49.17,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":29200},"source":{"system":"sec-edgar","filing":"0001415889-25-001936","document":"form4-01232025_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925001936/form4-01232025_090130.xml","form_type":"4"}},{"id":1296430,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T16:28:33.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on each annual anniversary of December 15, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":53600,"source":{"system":"sec-edgar","filing":"0001415889-25-001936","document":"form4-01232025_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588925001936/form4-01232025_090130.xml","form_type":"4"}},{"id":1451219,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-19T09:04:32.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock.  50% of the RSUs subject to the award shall vest on the NDA Approval Date and 50% of the RSUs subject to the award shall vest on the one year anniversary of the NDA Approval Date, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001415889-24-019812","document":"form4-07192024_010728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000141588924019812/form4-07192024_010728.xml","form_type":"4"}},{"id":3626532,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-28T17:34:17.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on February 27, 2020, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":26000,"derivative":{"exercise_price":8.53,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000899243-19-005278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000089924319005278/doc4.xml","form_type":"4"}},{"id":3813011,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":46467,"kind":"person","name":"Manning Meredith","position":1,"cik":"0001752631","reported_name":"Manning Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-18T16:50:14.000Z","date":"2018-09-17","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on September 17, 2019, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":175000,"derivative":{"exercise_price":13.94,"expiration_date":"2028-09-16","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-18-024668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752631/000089924318024668/doc4.xml","form_type":"4"}}]}